Literature DB >> 33704461

Fate or coincidence: do COPD and major depression share genetic risk factors?

Victoria L Martucci1,2, Bradley Richmond3,4, Lea K Davis1,2,5, Timothy S Blackwell3,4,6, Nancy J Cox1,2, David Samuels1,7, Digna Velez Edwards1,8,9, Melinda C Aldrich1,2,9,10,11.   

Abstract

Major depressive disorder (MDD) is a common comorbidity in chronic obstructive pulmonary disease (COPD), affecting up to 57% of patients with COPD. Although the comorbidity of COPD and MDD is well established, the causal relationship between these two diseases is unclear. A large-scale electronic health record clinical biobank and genome-wide association study summary statistics for MDD and lung function traits were used to investigate potential shared underlying genetic susceptibility between COPD and MDD. Linkage disequilibrium score regression was used to estimate genetic correlation between phenotypes. Polygenic risk scores (PRS) for MDD and lung function traits were developed and used to perform a phenome-wide association study (PheWAS). Multi-trait-based conditional and joint analysis identified single-nucleotide polymorphisms (SNPs) influencing both lung function and MDD. We found genetic correlations between MDD and all lung function traits were small and not statistically significant. A PRS-MDD was significantly associated with an increased risk of COPD in a PheWAS [odds ratio (OR) = 1.12, 95% confidence interval (CI): 1.09-1.16] when adjusting for age, sex and genetic ancestry, but this relationship became attenuated when controlling for smoking history (OR = 1.08, 95% CI: 1.04-1.13). No significant associations were found between the lung function PRS and MDD. Multi-trait-based conditional and joint analysis identified three SNPs that may contribute to both traits, two of which were previously associated with mood disorders and COPD. Our findings suggest that the observed relationship between COPD and MDD may not be driven by a strong shared genetic architecture.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 33704461      PMCID: PMC8120137          DOI: 10.1093/hmg/ddab068

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  109 in total

1.  Progress in disease progression genetics: dissecting the genetic origins of lung function decline in COPD.

Authors:  Robert Busch; Michael H Cho; Edwin K Silverman
Journal:  Thorax       Date:  2017-03-14       Impact factor: 9.139

2.  Gender differences in COPD: are women more susceptible to smoking effects than men?

Authors:  Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

3.  Defining Phenotypes from Clinical Data to Drive Genomic Research.

Authors:  Jamie R Robinson; Wei-Qi Wei; Dan M Roden; Joshua C Denny
Journal:  Annu Rev Biomed Data Sci       Date:  2018-04-25

Review 4.  Depression and anxiety in patients with COPD.

Authors:  Abebaw M Yohannes; George S Alexopoulos
Journal:  Eur Respir Rev       Date:  2014-09

5.  Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.

Authors:  Joshua C Denny; Lisa Bastarache; Marylyn D Ritchie; Robert J Carroll; Raquel Zink; Jonathan D Mosley; Julie R Field; Jill M Pulley; Andrea H Ramirez; Erica Bowton; Melissa A Basford; David S Carrell; Peggy L Peissig; Abel N Kho; Jennifer A Pacheco; Luke V Rasmussen; David R Crosslin; Paul K Crane; Jyotishman Pathak; Suzette J Bielinski; Sarah A Pendergrass; Hua Xu; Lucia A Hindorff; Rongling Li; Teri A Manolio; Christopher G Chute; Rex L Chisholm; Eric B Larson; Gail P Jarvik; Murray H Brilliant; Catherine A McCarty; Iftikhar J Kullo; Jonathan L Haines; Dana C Crawford; Daniel R Masys; Dan M Roden
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

Review 6.  Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Authors:  Nicole Gray Weiskopf; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

7.  Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study.

Authors:  Robyn E Wootton; Rebecca C Richmond; Bobby G Stuijfzand; Rebecca B Lawn; Hannah M Sallis; Gemma M J Taylor; Gibran Hemani; Hannah J Jones; Stanley Zammit; George Davey Smith; Marcus R Munafò
Journal:  Psychol Med       Date:  2019-11-06       Impact factor: 7.723

8.  Genetic determinants of daytime napping and effects on cardiometabolic health.

Authors:  Hassan S Dashti; Iyas Daghlas; Jacqueline M Lane; Yunru Huang; Miriam S Udler; Heming Wang; Hanna M Ollila; Samuel E Jones; Jaegil Kim; Andrew R Wood; Michael N Weedon; Stella Aslibekyan; Marta Garaulet; Richa Saxena
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

Review 9.  Risk in Relatives, Heritability, SNP-Based Heritability, and Genetic Correlations in Psychiatric Disorders: A Review.

Authors:  Bart M L Baselmans; Loïc Yengo; Wouter van Rheenen; Naomi R Wray
Journal:  Biol Psychiatry       Date:  2020-06-10       Impact factor: 12.810

10.  The polygenic architecture of left ventricular mass mirrors the clinical epidemiology.

Authors:  Jonathan D Mosley; Rebecca T Levinson; Eric Farber-Eger; Todd L Edwards; Jacklyn N Hellwege; Adriana M Hung; Ayush Giri; Megan M Shuey; Christian M Shaffer; Mingjian Shi; Evan L Brittain; Wendy K Chung; Iftikhar J Kullo; Adelaide M Arruda-Olson; Gail P Jarvik; Eric B Larson; David R Crosslin; Marc S Williams; Ken M Borthwick; Hakon Hakonarson; Joshua C Denny; Thomas J Wang; Charles M Stein; Dan M Roden; Quinn S Wells
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.